RAM Investment Partners LLC Purchases New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

RAM Investment Partners LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,130 shares of the healthcare conglomerate's stock, valued at approximately $1,639,000. UnitedHealth Group makes up about 0.4% of RAM Investment Partners LLC's investment portfolio, making the stock its 21st biggest position.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Fort Washington Investment Advisors Inc. OH grew its stake in UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after acquiring an additional 1,465 shares in the last quarter. Sherbrooke Park Advisers LLC bought a new stake in UnitedHealth Group in the 4th quarter worth approximately $515,000. Full Sail Capital LLC grew its holdings in shares of UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after purchasing an additional 33 shares in the last quarter. Soros Fund Management LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $39,413,000. Finally, Silvercrest Asset Management Group LLC lifted its holdings in shares of UnitedHealth Group by 47.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock valued at $19,625,000 after acquiring an additional 12,550 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CFO John F. Rex acquired 17,175 shares of the firm's stock in a transaction on Friday, May 16th. The stock was acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer now owns 203,796 shares in the company, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer now owns 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Piper Sandler reduced their price target on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a research note on Monday, May 19th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $415.57.

UnitedHealth Group Stock Up 2.1%

UNH traded up $6.23 during trading on Friday, hitting $308.85. The stock had a trading volume of 13,584,804 shares, compared to its average volume of 7,465,895. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The stock has a 50 day simple moving average of $336.21 and a two-hundred day simple moving average of $454.51. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $280.17 billion, a PE ratio of 12.93, a PEG ratio of 1.43 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter last year, the business posted $6.91 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.